Annual Epidemiological Reports (AERs)

ECDC’s Annual Epidemiological Report is available as a series of individual epidemiological disease reports. 

All reports on this page are based on data retrieved from TESSy.[1] Countries participating in disease surveillance submitted their data electronically. The year given in the title (i.e. 'Annual epidemiological report for 2015') refers to the year the data were collected.

The communicable diseases and related health issues covered by the below reports are under European Union and European Economic Area disease surveillance [2],[3],[4],[5],[6]. 

ECDC’s annual surveillance reports provide a wealth of epidemiological data to support decision-making at the national level. They are mainly intended for public health professionals and policymakers involved in disease prevention and control programmes.

Diseases and health topics    Annual Epidemiological Reports
  2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Anthrax        2022 2021 2020 2019 2018 2017 2016 2015 2014
Antimicrobial consumption 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Antimicrobial resistance (EARS-Net) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Botulism       2022 2021 2020 2019 2018 2017 2016 2015 2014
Brucellosis       2022 2021 2020 2019 2018 2017 2016 2015 2014
Campylobacteriosis       2022 2021 2020 2019 2018 2017 2016 2015 2014
Chikungunya virus disease       2022 2021 2020 2019 2018 2017 2016 2015 2014
Chlamydia infection   2024 2023 2022 2021   2019 2018 2017 2016 2015 2014
Cholera [7]       2022 2021 N/A 2019 2018 2017 2016 2015 2014
Communicable disease threats
to public health in the EU
          2020 2019 2018 2017 2016 N/A N/A
Creutzfeldt-Jakob disease, variant       2022 2021 2020 2019 2018 2017 2016 2015 2014
Crimean-Congo haemorrhagic fever        2022 2021 2020 2019 2018 2017 2016 2015 2014
Cryptosporidiosis         2021 2020 2019 2018 2017 2016 2015 2014
Dengue       2022 2021 2020 2019 2018 2017 2016 2015 2014
Diphtheria    2024 2023 2022 2021     2018 2017 2016 2015 2014
Ebola and Marburg virus diseases             2019 2018 2017 2016 2015 2014
Echinococcosis        2022 2021 2020 2019 2018 2017 2016 2015 2014
Giardiasis (lambliasis)       2022 2021 2020 2019 2018 2017 2016 2015 2014
Gonorrhoea   2024 2023 2022 2021   2019 2018 2017 2016 2015 2014
Haemophilus influenzae infection, 
invasive disease 
    2023 2022 2021     2018 2017 2016 2015 2014
Hantavirus infection     2023   2021 2020 2019 2018 2017 2016 2015 2014
Healthcare-associated infections: 
C. difficile infections
      2018-2020 2017 2016 N/A N/A
Healthcare-associated infections
 in intensive care units
      2022 2021 2020 2019 2018 2017 2016 2015 2014
Healthcare-associated infections: 
surgical site infections 
    2023 2021-2022 2018-2020 2017 2016 2015 2014
Hepatitis A        2022 2021 2020 2019 2018 2017 2016 2015 2014
Hepatitis B    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Hepatitis C     2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
HIV infection and AIDS                  2017 2016 2015 2014
Influenza, seasonal      2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Influenza, zoonotic    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Lassa fever              2019 2018 2017 2016 2015 2014
Legionnaires' disease    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Leptospirosis        2022 2021 2020 2019 2018 2017 2016 2015 2014
Listeriosis      2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Lymphogranuloma venereum   2024 2023 2022 2021   2019 2018 2017 2016 2015 2014
Malaria        2022 2021 2020 2019 2018 2017 2016 2015 2014
Meningococcal infection, invasive disease   2024 2023 2022 2021     2018 2017 2016 2015 2014
Measles   2024 2023 2022     2019 2018 2017  separate report series
Mumps      2023 2022 2021     2018 2017 2016 2015 2014
Pertussis    2024 2023 2022 2021     2018 2017 2016 2015 2014
Plague             2019 2018 2017 2016 2015 2014
Pneumococcal disease, invasive      2023 2022       2018 2017 2016 2015 2014
Poliomyelitis                2018 2017 2016 2015 2014
Q fever              2019 2018 2017 2016 2015 2014
Rabies              2019 2018 2017 2016 2015 2014
Rift Valley fever          2021   2019 2018 2017 2016 2015 2014
Rubella                 2017  separate report series
Salmonellosis     2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Severe acute respiratory syndrome 
(SARS) [8]
              N/A N/A N/A 2015 2014
Shiga toxin/verocytotoxin-producing 
E. coli (STEC/VTEC) infection 
    2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Shigellosis        2022 2021 2020 2019 2018 2017 2016 2015 2014
Smallpox              2019 2018 2017 2016 2015 2014
Syphilis    2024 2023 2022 2021   2019 2018 2017 2016 2015 2014
Syphilis, congenital   2024 2023 2022 2021   2019 2018 2017 2016 2015 2014
Tetanus    2024 2023 2022 2021     2018 2017 2016 2015 2014
Tick-borne encephalitis        2022 2021 2020 2019 2018 2017 2016 2015 2014
Toxoplasmosis, congenital         2021 2020 2019 2018 2017 2016 2015 2014
Trichinellosis        2022 2021 2020 2019 2018 2017 2016 2015 2014
Tuberculosis        2022 2021 2020 2019 2018 2017 2016 2015 2014
Tularaemia              2019 2018 2017 2016 2015 2014
Typhoid and paratyphoid fevers          2021 2020 2019 2018 2017 2016 2015 2014
West Nile virus infection             2019 2018 2017 2016 2015 2014
Yellow fever              2019 2018 2017 2016 2015 2014
Yersiniosis        2022 2021 2020 2019 2018 2017 2016 2015 2014
Zika virus disease       2022 2021 2020 2019 2018 2017 2016 N/A N/A

_________________________________

  1. The European Surveillance System (TESSy) is a system for the collection, analysis and dissemination of data on communicable diseases. EU Member States and EEA countries contribute to the system by uploading their infectious disease surveillance data at regular intervals.
  2. 2000/96/EC: Commission Decision of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official Journal, OJ L 28, 03.02.2000, p. 50–53.
  3. 2003/534/EC: Commission Decision of 17 July 2003 amending Decision No 2119/98/EC of the European Parliament and of the Council and Decision 2000/96/EC as regards communicable diseases listed in those decisions and amending Decision 2002/253/EC as regards the case definitions for communicable diseases. Official Journal, OJ L 184, 23.07.2003, p. 35–39.
  4. 2007/875/EC: Commission Decision of 18 December 2007 amending Decision No 2119/98/EC of the European Parliament and of the Council and Decision 2000/96/EC as regards communicable diseases listed in those decisions. Official Journal, OJ L 344, 28.12.2007, p. 48–49.
  5. Commission Decision 2119/98/EC of the Parliament and of the Council of 24 September 1998 setting up a network for the epidemiological surveillance and control of communicable diseases in the Community. Official Journal, OJ L 268, 03/10/1998 p. 1–7.
  6. 2002/253/EC: Commission Decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official Journal, OJ L 86, 03.04.2002, p. 44–62.
  7. No cases of cholera were reported in the EU in 2020
  8. No cases of SARS virus infection in humans have been reported worldwide since 2003.

Archive with older reports

Page last updated